Göttle, Peter
Förster, Moritz
Weyers, Vivien
Küry, Patrick
Rejdak, Konrad
Hartung, Hans-Peter
Kremer, David
Article History
Received: 11 March 2019
Accepted: 14 May 2019
First Online: 8 July 2019
Ethics approval and consent to participate
: This manuscript does not involve the use of any animal or human data or tissues.
: Not applicable.
: PG and PK performed consultancy work for GeNeuro. HPH received consultancy fees and fees for serving on steering or data monitoring committees and adboards from Bayer Healthcare, Biogen, GeNeuro, Genzyme, MedDay, Merck, Novartis, Celgene Receptos, Roche, Teva with approval by the Rector of Heinrich-Heine-University. DK received travel grants from GeNeuro and Merck, refund of congress participation fees from GeNeuro, Merck, Servier, consulting fees from Grifols, payment for lectures from Grifols and support for research projects from Teva. MF, VW and KR declare that they have no competing interests.